Background Available psoriasis surveys offer valuable information about psoriasis and psoriatic
arthritis (PsA), but are limited by methodology or enrollment requirements. Objective To …

This prospective long-term cohort study investigated the incidence of malignancies in
severe psoriasis patients treated with cyclosporine. A total of 1252 patients were followed …

Systemic use of immunosuppressant agents increases the risk of lymphoma in transplantation.
We performed a nested case–control study in the PharMetrics database to evaluate the …

… Université Paul Sabatier, CNRS, and Pierre Fabre; has received royalties from Université
Paul Sabatier Toulouse; and has received travel support from Roche-Schugai (France). CF …

A key challenge in psoriasis therapy is the tendency for lesions to recur in previously affected
anatomical locations after treatment discontinuation following lesion resolution. Available …

Although the demand for evidence-based decisions is increasing in clinical practice, recent
systematic reviews on the accuracy of existing psoriasis severity scales, including the …

OBJECTIVE: We sought to compare pharmacokinetics of pimecrolimus cream 1% and
tacrolimus ointment 0.1% in adults with extensive, moderate to severe atopic dermatitis. …

Benefit–risk assessment of systemic treatment in psoriasis is a dynamic process. Long-term
safety of psoriasis therapies has been questioned, with the spectrum of systemic …

Background and Objective Previous large studies have highlighted the impact of psoriasis on
health-related quality of life (HRQoL) but not on interpersonal touch. This survey assessed …

Having organized 2 highly successful Fellows symposia in 2012 and 2013, the Group for
Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) was able to continue …